Agilent Technologies (A) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Agilent Technologies (A)

139.80

+1.43 (1.03%)

as of Aug 3, 2026, 8:00:00 pm Market Open.

6 watching

Investor Insights

Aug 3, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Agilent Technologies has recently garnered mixed reviews from experts in light of its latest reporting. While one expert notes that the company missed expectations in the previous quarter and calls for a strong narrative around its pharmaceutical segment, another review highlights a significant recovery, with the stock rising 55% from its April lows. The latter expert emphasizes a solid quarter with a 7% organic growth rate, crediting re-shoring trends in life sciences and the growing demand for certain medicines that require enhanced hardware production. Additionally, the FDA's impact has been less disruptive than anticipated, leading to a more favorable outlook for the life sciences sector. Overall, there are signs of a turnaround for Agilent, albeit with some caution regarding its performance metrics.

Consensus

Mixed

Valuation

Fair Value

Similar

ThermoFisher, TMO

TOP PICK

The knock on this company had been that they were very concentrated in the Olds area of Alberta, but they have now expanded outside that area. Low declines and lots of drilling prospects.

TRADE

Trust conversion is becoming controversial because of vote allowing option holders to vote and large windfall to employees. The windfall is not that large. Likes this trust. Gas weighted. Well operated.

WEAK BUY

A little disappointed by the last 3 quarters and its ability to make its projections. Has a great group of properties in N.E. British Columbia and N.W. Alberta. Multi-zoned which gives it a better chance of making its production.

BUY

Q: Preference between Novelis (NVL-T) and this company? A: Prefers the metal producer Alcan over the packager. This company, relying on aluminum prices, can be more volatile, but he's a believer in aluminum prices.

BUY

WAIT

Eliot Spitzer investigation has touched this company and put pressure on the stock. New CEO and not sure of him. In a lot of emerging markets which are growing very rapidly. Good as a one-stop financial stop, but you need a good long term view.

BUY

Have done very well. New drilling rigs which require fewer people to operate and can drill more quickly. Will probably be a takeout down the road.

BUY

DON'T BUY

Felt that John Chambers and Cisco's endorsement was very exciting. After thinking the accounting was being cleaned up, it turned out there is far more than expected. This has created a lack of credibility.

BUY

They don't own because it is such a thin trading stock. They have done a very good job and have good assets and good management.

DON'T BUY

Not bullish on the price of natural gas. Will be a market perform.

BUY

Sees improving fundamentals. A nice exposure to rising commodity prices. Possibly some acquisitions in the future. Expect it to go higher.

Showing 16 to 30 of 32 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

The Monthly Gems by Allan Tong

Stockchase

Amy Raskin, CIO, Chevy Chase Trust

Chevy Chase Trust

Stephanie Link, Chief investment strategist, Hightower

Hightower

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Agilent Technologies (A)